To confirm this, we performed a cycloheximide (CHX) assay to evaluate the half‐life of δ‐catenin protein in gastric cancer cells treated with si‐NC and si‐MALAT1 M2‐EX at different times. This evidence concerns the gene MALAT1 and gastric cancer.